Synthego Corp Stock
Synthego is a leading provider of genome engineering solutions. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.
Sign up for SecondMarket™ to view the market and buy or sell Synthego Corp Stock
Buy + SellSynthego Corp Funding
Sign up to gain insights into Synthego Corp funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Dec 31, 2021 | Series E | 135.00M | ||
Jun 11, 2020 | Series D | 100.00M | ||
Oct 09, 2018 | Series C | 106.27M | ||
Dec 21, 2016 | Series B | 40.70M | ||
Jun 26, 2013 | Series A | 8.29M |
See Synthego Corp Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Synthego Corp Stock Valuation + Share Prices
View real-time Tape D™ data on Synthego Corp stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedSynthego Corp Management Team
Chief Innovation Officer
Fabian Gerlinghaus
Chief Operating Officer
John Tan
Chief Scientific Officer
Robert Deans
Director
Drew Oetting
CEO, Director
Paul Dabrowski
President, Director
Michael Dabrowski
Director
Scott Nolan
Synthego Corp Major Investors
Intel Capital Corp
Wellington Management Company LLP
Logos Capital
Moore Strategic Ventures
Menlo Ventures
Perceptive Advisors, LLC
Perceptive Advisors, LLC
Gigafund
Chimera Partners Ltd
8VC
Declaration Partners
WI Harper Group Inc
Laurion Capital Management
Softbank Vision Fund 2
The Founders Fund
RA Capital Management LLC